Dual edged mechanisms of a tomatine in hepatocellular carcinoma by suppression of Wnt/b Catenin signaling versus RelB driven resistance in tumor therapy
Background: The plant-derived steroidal alkaloid a-tomatine has emerged as a promising pan-cancer therapeutic agent, its multifaceted biological effects in HCC remain unexplored. This study aims to decipher a-tomatine's molecular duality in HCC, resolving its paradoxical capacity to simultaneously activate tumor-suppressive signaling and provoke chemoresistance networks, ultimately establishing synergistic phytotherapy strategies. Methods: HepG2 hepatocellular carcinoma cells were exposed to a-tomatine to evaluate dose-dependent effects on proliferation, migration/ invasion, and cell cycle distribution. Transcriptomic pro ling via RNA sequencing identi ed dysregulated pathways. Pharmacological interventions using Wnt3a (activation) and XAV939 (inhibition) modulated Wnt/ß-catenin signaling, while CRISPR/Cas9-mediated RelB knockout and plasmid-based overexpression established isogenic cell models. These interventions were subsequently applied in BALB/c nude mouse xenografts, where tumor volume was longitudinally monitored during a-tomatine treatment. Results: a-Tomatine demonstrated dose-dependent suppression of hepatocellular carcinoma cell proliferation, migration, and invasion, concomitant with G2/M phase arrest. Mechanistically, it exerted Wnt/ß- catenin inhibition via ß-catenin phosphorylation/degradation while paradoxically inducing RelB-mediated reduction of anti-tumor activity. Wnt activation attenuated therapeutic effects, whereas Wnt inhibitors enhanced ef cacy. Genetic RelB ablation potentiated a-tomatine's anti-tumor activity, contrasting with resistance in RelB-overexpressing models. Xenografts con rmed enhanced suppression in RelB-de cient tumors. Conclusion: This plant-derived alkaloid exerts anti-HCC effects through Wnt pathway modulation, while compensatory RelB activation constrains therapeutic outcomes. Strategic RelB co-targeting establishes a dual pathway phytotherapy paradigm, synergistically merging botanical pharmacodynamics with precision Overall design: HepG2 cells were treated with 2uM a-tomatine for 6h, 12h and 24h. The bulk RNA-seq profiling was done to identify the differential expressed genes.